{"id":"https://openalex.org/W2061874656","doi":"https://doi.org/10.1089/108076803322279426","title":"Ocular Side-Effects Associated with Imatinib Mesylate (Gleevec \u00ae )","display_name":"Ocular Side-Effects Associated with Imatinib Mesylate (Gleevec \u00ae )","alternate_titles":[],"publication_year":2003,"publication_date":"2003-08-01","ids":{"openalex":"https://openalex.org/W2061874656","doi":"https://doi.org/10.1089/108076803322279426","mag":"2061874656","pmid":"https://pubmed.ncbi.nlm.nih.gov/12964961"},"language":"en","primary_location":{"id":"doi:10.1089/108076803322279426","doi":"https://doi.org/10.1089/108076803322279426","is_oa":false,"landing_page_url":"https://doi.org/10.1089/108076803322279426","pdf_url":null,"source":{"id":"https://openalex.org/S192126995","display_name":"Journal of Ocular Pharmacology and Therapeutics","issn_l":"1080-7683","issn":["1080-7683","1557-7732","8756-3320"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Ocular Pharmacology and Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2061874656"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113692308","display_name":"Frederick Web Fraunfelder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Frederick W. Fraunfelder","raw_affiliation_strings":["Casey Eye Institute, Portland OR","Casey Eye Institute, Portland OR 97201, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Casey Eye Institute, Portland OR","institution_ids":[]},{"raw_affiliation_string":"Casey Eye Institute, Portland OR 97201, USA","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069150950","display_name":"Jonathan Solomon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jonathan Solomon","raw_affiliation_strings":["Casey Eye Institute, Portland OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Casey Eye Institute, Portland OR","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125591963","display_name":"Brian J. Druker","orcid":"https://orcid.org/0000-0001-8331-8206","observed_orcids":["https://orcid.org/0000-0001-8331-8206"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Brian J. Druker","raw_affiliation_strings":["Oregon Health & Science University Cancer Institute, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health & Science University Cancer Institute, Portland, OR","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076491232","display_name":"Bita Esmaeli","orcid":"https://orcid.org/0000-0002-3667-1821","observed_orcids":["https://orcid.org/0000-0002-3667-1821","https://orcid.org/0009-0005-2588-6754"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bita Esmaeli","raw_affiliation_strings":["Ophthalmology Section, University of Texas M.D. Anderson Cancer Center, Houston, TX","Plastic Surgery"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology Section, University of Texas M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Plastic Surgery","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056620493","display_name":"Jennifer M. Kuyl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jennifer Kuyl","raw_affiliation_strings":["Oregon Health & Science University Cancer Institute, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health & Science University Cancer Institute, Portland, OR","institution_ids":["https://openalex.org/I165690674"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.2359,"has_fulltext":false,"cited_by_count":132,"citation_normalized_percentile":{"value":0.85644111,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"19","issue":"4","first_page":"371","last_page":"375"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imatinib-mesylate","display_name":"imatinib mesylate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.9210000038146973},{"id":"https://openalex.org/keywords/ocular-adverse-drug-reactions","display_name":"ocular adverse drug reactions","score":0.8109999895095825},{"id":"https://openalex.org/keywords/periorbital-edema","display_name":"periorbital edema","score":0.984000027179718},{"id":"https://openalex.org/keywords/epiphora","display_name":"epiphora","score":1.0},{"id":"https://openalex.org/keywords/drug-induced-ocular-side-effects","display_name":"drug-induced ocular side effects","score":0.6890000104904175},{"id":"https://openalex.org/keywords/extraocular-muscle-palsy","display_name":"extraocular muscle palsy","score":0.8360000252723694},{"id":"https://openalex.org/keywords/blepharoconjunctivitis","display_name":"blepharoconjunctivitis","score":0.9359999895095825},{"id":"https://openalex.org/keywords/glaucoma","display_name":"glaucoma","score":0.8299999833106995},{"id":"https://openalex.org/keywords/papilledema","display_name":"papilledema","score":0.6430000066757202},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitor-toxicity","display_name":"tyrosine kinase inhibitor toxicity","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9020429849624634},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.8995836973190308},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5706928372383118},{"id":"https://openalex.org/C3454156","wikidata":"https://www.wikidata.org/wiki/Q1144241","display_name":"Side effect (computer science)","level":2,"score":0.5592115521430969},{"id":"https://openalex.org/C2780886150","wikidata":"https://www.wikidata.org/wiki/Q152234","display_name":"Edema","level":2,"score":0.5317239761352539},{"id":"https://openalex.org/C2781194658","wikidata":"https://www.wikidata.org/wiki/Q622427","display_name":"Ptosis","level":2,"score":0.4898645579814911},{"id":"https://openalex.org/C2776521421","wikidata":"https://www.wikidata.org/wiki/Q9294051","display_name":"Ocular hypertension","level":3,"score":0.4714411497116089},{"id":"https://openalex.org/C2780194963","wikidata":"https://www.wikidata.org/wiki/Q903441","display_name":"Mesylate","level":2,"score":0.45788896083831787},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.42870795726776123},{"id":"https://openalex.org/C2781092963","wikidata":"https://www.wikidata.org/wiki/Q650050","display_name":"Intraocular pressure","level":2,"score":0.4036286175251007},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.30486705899238586},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1562890112400055},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004487","descriptor_name":"Edema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004487","descriptor_name":"Edema","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005128","descriptor_name":"Eye Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D005128","descriptor_name":"Eye Diseases","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":true},{"descriptor_ui":"D005128","descriptor_name":"Eye Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007766","descriptor_name":"Lacrimal Apparatus Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007766","descriptor_name":"Lacrimal Apparatus Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/108076803322279426","doi":"https://doi.org/10.1089/108076803322279426","is_oa":false,"landing_page_url":"https://doi.org/10.1089/108076803322279426","pdf_url":null,"source":{"id":"https://openalex.org/S192126995","display_name":"Journal of Ocular Pharmacology and Therapeutics","issn_l":"1080-7683","issn":["1080-7683","1557-7732","8756-3320"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Ocular Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:12964961","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12964961","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1965840806","https://openalex.org/W1995930366","https://openalex.org/W1997499809","https://openalex.org/W2015015957","https://openalex.org/W2121032564","https://openalex.org/W2137063143","https://openalex.org/W2147124043","https://openalex.org/W2312804644","https://openalex.org/W2329648702","https://openalex.org/W2406519044"],"related_works":["https://openalex.org/W1974467129","https://openalex.org/W1197116825","https://openalex.org/W2136703362","https://openalex.org/W1966393112","https://openalex.org/W2112902291","https://openalex.org/W2012848834","https://openalex.org/W2060759378","https://openalex.org/W6931363058","https://openalex.org/W1607243339"],"abstract_inverted_index":{"This":[0],"retrospective":[1],"case":[2],"series":[3],"describes":[4],"ocular":[5,43,151,170],"side-effects":[6,115,152,171],"associated":[7],"with":[8,40],"imatinib":[9,27,93,155,161],"mesylate":[10,28,156,162],"(Gleevec)":[11],"and":[12,52,59,85,138,144],"the":[13,50,55,60,78,147],"clinical":[14],"characteristics":[15,159],"of":[16,23,63,77,105,110,114,160,169,179],"these":[17],"adverse":[18],"reactions.":[19],"A":[20],"chart":[21],"review":[22],"104":[24],"patients":[25,79,87],"on":[26],"therapy":[29],"from":[30,49],"Oregon":[31],"Health":[32,57],"&":[33],"Science":[34],"University's":[35],"Cancer":[36],"Center":[37],"were":[38,68],"studied":[39],"regard":[41],"to":[42,154],"side-effects.":[44],"In":[45],"addition,":[46],"spontaneous":[47],"reports":[48],"Food":[51],"Drug":[53],"Administration,":[54],"World":[56],"Organization,":[58],"National":[61],"Registry":[62],"Drug-Induced":[64],"Ocular":[65],"Side-Effects":[66],"databases":[67],"reviewed,":[69],"including":[70],"a":[71],"Medline":[72],"literature":[73],"search.":[74],"Seventy-three":[75],"(70%)":[76],"at":[80],"OHSU":[81],"developed":[82,89],"periorbital":[83,120,164,182],"edema":[84,101,143,165],"19":[86],"(18%)":[88],"epiphora":[90,145],"after":[91,108],"receiving":[92],"mesylate.":[94],"Average":[95],"dose":[96],"was":[97],"407.5+/-60":[98],"mg.":[99],"Periorbital":[100,142],"occurred":[102],"an":[103],"average":[104],"68+/-48":[106],"days":[107],"initiation":[109],"therapy.":[111,157],"WHO":[112],"classification":[113],"is":[116,172],"as":[117],"follows:":[118],"certain:":[119],"edema;":[121],"probable:":[122],"epiphora;":[123],"possible:":[124],"extraocular":[125],"muscle":[126],"palsy,":[127],"ptosis,":[128],"blepharoconjunctivitis;":[129],"unlikely:":[130],"glaucoma,":[131],"papilledema,":[132],"retinal":[133],"hemorrhage,":[134],"photosensitivity,":[135],"abnormal":[136],"vision,":[137],"increased":[139],"intraocular":[140],"pressure.":[141],"are":[146,166],"two":[148],"most":[149],"common":[150],"related":[153],"Clinical":[158],"induced":[163],"described.":[167],"Management":[168],"conservative":[173],"except":[174],"in":[175],"very":[176],"rare":[177],"cases":[178],"visually":[180],"significant":[181],"edema.":[183]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2061874656","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
